Your landing page’s weakest score is Trust.
How BioNTech ranks
category scores
category scoresShowHide
Trust
48PoorProof that the product is real, competent, and safe to try.



| Trust read | |
|---|---|
| BioNTech | Nav links to "Investors", "Clinical trials" and "Healthcare professionals" |
| No visible trust signal identified. | |
| Headline "Recapping Positive Phase 3 Topline Results for Intismeran Autogene Plus Pembrolizumab in Adjuvant Melanoma" | |
| "CureVac is now part of the BioNTech Group (Nasdaq: BNTX)" acquisition statement on the desktop fold | |
| No visible trust signal identified. |
Value props
55FairTitle, subtitle, hero — do they sell the product's true value?
We are a global immunotherapy powerhouse aspiring to translate science into survival
Working
- 'Science into survival' is memorable
- Names the immunotherapy category
- Emotional stakes: survival
Could improve
- No subhead or proof points
- 'Powerhouse aspiring' is empty puffery
- Hero video decorates, shows nothing
CTA
58FairCopy, size, verb, cost-feel — does the primary CTA earn the click?

How BioNTech compares
Recommended rewrites
Information hierarchy
62FairDoes the design help or inhibit what the page is trying to say?

What works
What to improve
Mobile web
62FairThe phone experience as a first-class citizen.

What works
What to improve
